← All companies
SABS
SAB Biotherapeutics, Inc.
$0.02
-0.00 -15.00%
Key statistics
from XBRL data in SEC filingsMarket cap
$1.30M
Revenue (TTM)
$2.78M
Net income (TTM)
-$398K
EPS (TTM)
$-0.58
P/E ratio
—
Dividend yield
—
Free cash flow
-$45.7M
Cash
$20.5M
Total assets
$248M
Gross margin
—
52-week range
$0.02 – $0.02
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Regulation FD disclosure
Jul 7, 2026
8-K
Shareholder vote results
Jun 18, 2026
10-Q
Quarter ended 2026-03-31
May 12, 2026
8-K
Entered a material agreement
May 4, 2026
8-K
Regulation FD disclosure
Apr 22, 2026
8-K
Entered a material agreement; Other events
Mar 19, 2026
8-K
Regulation FD disclosure; Other events
Mar 10, 2026
10-K
Fiscal year ended 2025-12-31
Mar 9, 2026
8-K
Regulation FD disclosure
Jan 12, 2026
8-K
Director or officer change; Regulation FD disclosure
Jan 7, 2026
8-K
Other events
Dec 29, 2025
10-Q
Quarter ended 2025-09-30
Nov 14, 2025
8-K
Director or officer change
Sep 30, 2025
8-K
Director or officer change; Shareholder vote results
Sep 26, 2025
10-Q
Quarter ended 2025-06-30
Aug 7, 2025
8-K
Entered a material agreement; Unregistered sale of equity; Amended charter or bylaws; Other events
Jul 21, 2025
8-K
Shareholder vote results
Jul 17, 2025
10-Q
Quarter ended 2025-03-31
May 9, 2025
10-K
Fiscal year ended 2024-12-31
Mar 31, 2025
8-K
Entered a material agreement; Completed an acquisition or disposition
Feb 5, 2025
8-K
Other events
Jan 28, 2025
10-Q
Quarter ended 2024-09-30
Nov 6, 2024
8-K
Regulation FD disclosure
Sep 9, 2024
10-Q
Quarter ended 2024-06-30
Aug 8, 2024
8-K
Director or officer change; Regulation FD disclosure
Jul 31, 2024
8-K
Shareholder vote results
Jun 27, 2024
8-K
Director or officer change; Regulation FD disclosure
May 31, 2024
8-K
Other events
May 21, 2024
10-Q
Quarter ended 2024-03-31
May 20, 2024
8-K
Director or officer change; Regulation FD disclosure
May 8, 2024
8-K
Regulation FD disclosure
Apr 15, 2024
8-K
Results of operations (earnings release)
Mar 29, 2024
10-K
Fiscal year ended 2023-12-31
Mar 29, 2024
8-K
Entered a material agreement; Director or officer change
Mar 8, 2024
8-K
Director or officer change; Regulation FD disclosure
Feb 2, 2024
8-K
Entered a material agreement
Jan 26, 2024
8-K
Other events
Jan 25, 2024
8-K
Regulation FD disclosure
Jan 19, 2024
8-K
Modified rights of security holders; Amended charter or bylaws; Shareholder vote results; Regulation FD disclosure
Jan 3, 2024
8-K
Regulation FD disclosure
Nov 29, 2023